7-day fecal molecular susceptibility-guided therapy: Clinical Trials

2 trials of 7-day fecal molecular susceptibility-guided therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 2

Follow 7-day fecal molecular susceptibility-guided therapy: new trials by email Literature Review of 7-day fecal molecular susceptibility-guided therapy trials Research Report on 7-day fecal molecular susceptibility-guided therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fecal Molecular Susceptibility-guided Hp First-line Therapy
7-day fecal molecular susceptibility-guided therapy, 14-day fecal molecular susceptibility-guided therapy - HELICOBACTER PYLORI INFECTIONS
Phase 4Not yet recruitingShanghai Zhongshan Hospital5442026-02-282026-02-12
Fecal Molecular Susceptibility-guided Hp Rescue Therapy
7-day fecal molecular susceptibility-guided therapy, 14-day fecal molecular susceptibility-guided therapy - Helicobacter Pylori Infection
Phase 4Not yet recruitingShanghai Zhongshan Hospital2902026-02-282026-02-12

Sponsors

Shanghai Zhongshan Hospital (2)

Countries

China (2)

Top investigators

Hong Gao, MD (1)